- Investing Ideas
- /
- German Undervalued Stocks Based On Cash Flows
German Undervalued Stocks Based On Cash Flows
Results
27
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
27 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
CY1K | €2.86 | -1.4% | -57.9% | €26.8m | €7.00 | PB0.8x | E102.7% | n/a | Capital Goods | ||
VTSC | €56.55 | -4.8% | -27.0% | €2.3b | €74.72 | PB0.8x | E62.7% | 0.4% | Automobiles | ||
SBS | €41.45 | -2.5% | -18.4% | €503.9m | €42.33 | PE41.5x | E21.9% | 1.3% | Healthcare | ||
HNL | €17.60 | 7.0% | -21.1% | €106.7m | €25.20 | PS1.1x | E121.4% | n/a | Capital Goods | ||
STM | €42.25 | -3.8% | -19.4% | €1.0b | €63.44 | PE14.2x | E20.5% | 4.1% | Capital Goods | ||
RTV | €2.48 | -3.1% | -3.9% | €37.9m | €2.80 | PS13.5x | E116.8% | n/a | Media | ||
CHG | €24.00 | -1.6% | 65.5% | €469.2m | €27.00 | PS6.6x | E73.4% | n/a | Healthcare | ||
TTR1 | €17.00 | -5.6% | -33.1% | €117.4m | €21.50 | PE18.4x | E29.4% | 3.6% | Capital Goods | ||
MTX | €253.10 | 1.6% | 21.4% | €13.6b | €250.14 | PS2.5x | E34.9% | 0.8% | Capital Goods | ||
RSL2 | €18.50 | -1.1% | -14.4% | €119.1m | €30.00 | PB1.7x | E58.9% | 0% | Capital Goods | ||
E4C | €12.75 | -1.9% | -32.5% | €44.8m | €40.50 | PE29.5x | E46.7% | 3.7% | Telecom | ||
AEIN | €16.70 | -1.2% | -30.4% | €191.1m | €32.63 | PE14.3x | E25.2% | 3.0% | Software | ||
SANT | €19.95 | 1.3% | 4.5% | €1.2b | €30.42 | PE16.4x | E21.1% | 2.5% | Software | ||
ADS | €232.60 | -0.4% | 31.1% | €41.5b | €233.72 | PE488.6x | E41.0% | 0.3% | Consumer Durables | ||
R3NK | €24.51 | -5.4% | n/a | €2.5b | €31.88 | PE77.8x | E32.8% | 1.2% | Capital Goods | ||
V3S | €10.65 | -1.8% | 106.4% | €85.8m | €10.25 | PS2.3x | E118.7% | 0% | Tech | ||
M12 | €15.30 | -12.3% | 89.4% | €280.2m | €27.50 | PE27.3x | E24.4% | 3.3% | Healthcare | ||
BSL | €10.50 | -0.2% | -33.7% | €322.7m | €15.70 | PS1.7x | E84.0% | 0% | Tech | ||
ISHA | €2.04 | 1.0% | 13.0% | €29.7m | €2.60 | PB2.7x | E80.5% | n/a | Software | ||
GXI | €96.05 | -4.0% | -10.6% | €3.3b | €134.06 | PE28.7x | E22.3% | 1.3% | Pharmaceuticals & Biotech | ||
SAP | €193.82 | 5.8% | 62.4% | €226.1b | €207.32 | PE87.2x | E37.3% | 1.1% | Software | ||
LPK | €7.95 | -2.8% | -2.8% | €194.6m | €12.05 | PE58.8x | E51.7% | n/a | Tech | ||
EQS | €39.40 | 0% | 90.3% | €394.9m | €37.50 | PS5.5x | E115.5% | 0% | Software | ||
SJJ | €11.90 | 6.3% | 42.3% | €125.0m | €19.75 | PS1.3x | E111.5% | 0% | Software |